These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 19059633)

  • 1. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
    Chen YX; Shen YM; Qian JH; Xie X
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor].
    Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
    Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
    Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
    Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
    Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
    Kang WD; Choi HS; Kim SM
    Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia.
    Boafo-Yirenki M; Everard J; Tidy J; Hancock BW
    J Reprod Med; 2009 May; 54(5):288-90. PubMed ID: 19517692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease.
    van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM
    J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy.
    Matsui H; Suzuka K; Yamazawa K; Tanaka N; Mitsuhashi A; Seki K; Sekiya S
    Gynecol Oncol; 2005 Mar; 96(3):616-20. PubMed ID: 15721402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
    Abrão RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
    Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
    Chalouhi GE; Golfier F; Soignon P; Massardier J; Guastalla JP; Trillet-Lenoir V; Schott AM; Raudrant D
    Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trophoblastic diseases].
    ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.
    Feng F; Xiang Y; Li L; Wan X; Yang X
    Gynecol Oncol; 2009 Jun; 113(3):312-5. PubMed ID: 19345988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
    Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
    Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.